Citius Oncology, Inc. Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update

B $5.6 million in net revenue for the first half of fiscal 2026 as LYMPHIR® launch progresses Up to $36.5 million in debt and equity…
posteditor
posteditor
Articles: 21727